# Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With BL/DLBCL

> **NCT03958916** · — · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 500 (estimated)

## Conditions studied

- Rituximab
- Lymphoma, Non-Hodgkin
- Pediatric Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03958916
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-05-05
- **Primary completion:** 2022-05-05
- **Final completion:** 2025-05-05
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2022-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03958916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03958916, "Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With BL/DLBCL". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT03958916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*